Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP865337.RAun7wS_79M2_KpF12n-vwLrn9v_m8WEHtLJ4CxoXvlKw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP865337.RAun7wS_79M2_KpF12n-vwLrn9v_m8WEHtLJ4CxoXvlKw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP865337.RAun7wS_79M2_KpF12n-vwLrn9v_m8WEHtLJ4CxoXvlKw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP865337.RAun7wS_79M2_KpF12n-vwLrn9v_m8WEHtLJ4CxoXvlKw130_provenance.
- NP865337.RAun7wS_79M2_KpF12n-vwLrn9v_m8WEHtLJ4CxoXvlKw130_assertion description "[Altogether, our findings identify Mdk as a pivotal factor involved in the resistance of glioma cells to THC pro-autophagic and antitumoral action, and suggest that selective targeting of the Mdk/ALK axis could help to improve the efficacy of antitumoral therapies for gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP865337.RAun7wS_79M2_KpF12n-vwLrn9v_m8WEHtLJ4CxoXvlKw130_provenance.
- NP865337.RAun7wS_79M2_KpF12n-vwLrn9v_m8WEHtLJ4CxoXvlKw130_assertion evidence source_evidence_literature NP865337.RAun7wS_79M2_KpF12n-vwLrn9v_m8WEHtLJ4CxoXvlKw130_provenance.
- NP865337.RAun7wS_79M2_KpF12n-vwLrn9v_m8WEHtLJ4CxoXvlKw130_assertion SIO_000772 21233844 NP865337.RAun7wS_79M2_KpF12n-vwLrn9v_m8WEHtLJ4CxoXvlKw130_provenance.
- NP865337.RAun7wS_79M2_KpF12n-vwLrn9v_m8WEHtLJ4CxoXvlKw130_assertion wasDerivedFrom befree-2016 NP865337.RAun7wS_79M2_KpF12n-vwLrn9v_m8WEHtLJ4CxoXvlKw130_provenance.
- NP865337.RAun7wS_79M2_KpF12n-vwLrn9v_m8WEHtLJ4CxoXvlKw130_assertion wasGeneratedBy ECO_0000203 NP865337.RAun7wS_79M2_KpF12n-vwLrn9v_m8WEHtLJ4CxoXvlKw130_provenance.
- befree-2016 importedOn "2016-02-19" NP865337.RAun7wS_79M2_KpF12n-vwLrn9v_m8WEHtLJ4CxoXvlKw130_provenance.